---
figid: PMC8746472__molecules-27-00284-g003
figtitle: 'Pharmacological Effects of Grifolin: Focusing on Anticancer Mechanisms'
organisms:
- Solanum lycopersicum
- Candida albicans
- Agaricus bisporus
- Aspergillus niger
- Fusarium graminearum
- Sclerotinia sclerotiorum
- Blumeria graminis
- Alternaria solani
- Rhododendron dauricum
- Ajuga iva
- Peperomia galioides
- Albatrellus ovinus
- Macrolepiota sp.
- Albatrellus dispansus
- Baorangia pseudocalopus
- Staphylococcus aureus
- Bacillus subtilis
- Salmonella enterica subsp. enterica serovar Typhimurium
- Bacillus cereus
- Mycobacterium avium
- Xanthomonas oryzae
- Shigella dysenteriae
- Mycolicibacterium phlei
- Leishmania donovani
- Leishmania amazonensis
- Leishmania braziliensis
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Callithrix jacchus
- Human gammaherpesvirus 4
- NA
- NA
- NA
- NA
pmcid: PMC8746472
filename: molecules-27-00284-g003.jpg
figlink: /pmc/articles/PMC8746472/figure/molecules-27-00284-f003/
number: F3
caption: 'Anticancer mechanisms of grifolin. Grifolin can mediate its anticancer actions
  through three fundamental mechanisms. (1) Grifolin can induce an increase of Bax
  and a decrease of Bcl2 in Mitochondria which exhibit a release of cytochrome C and
  an eventual increase of caspase 3 cleave PAPR proteins, thus inducing intrinsic
  apoptotic action. (2) Grifolin can inhibit the ERK1/2 pathway and increase the expression
  of DNMT1, which plays a key role in maintaining of cell memory with inhibiting cell
  proliferation. (3) Grifolin can induce senescence of cancerous cells through cell
  cycle arrest (via inhibiting inhibition CDK4, cyclin E, and cyclin D1 regulator
  proteins) and a decrease of RB phosphorylation. Abbreviations: DNMT1, DNA Methyltransferase
  1; ERK1/2, extracellular signal-regulated kinases 1 and 2; Bcl, B cell lymphoma;
  Bax, BCL2-associated X protein; RB, retinoblastoma protein; PARP, poly (ADP-ribose)
  polymerase; CDK, cyclin-dependent kinase.'
papertitle: 'Pharmacological Effects of Grifolin: Focusing on Anticancer Mechanisms.'
reftext: Abdelhakim Bouyahya, et al. Molecules. 2022 Jan;27(1):284.
year: '2022'
doi: 10.3390/molecules27010284
journal_title: Molecules
journal_nlm_ta: Molecules
publisher_name: MDPI
keywords: grifolin | pharmacodynamic | anticancer effect | NF-ÎºB | apoptosis
automl_pathway: 0.8280566
figid_alias: PMC8746472__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Callithrix jacchus
redirect_from: /figures/PMC8746472__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8746472__molecules-27-00284-g003.html
  '@type': Dataset
  description: 'Anticancer mechanisms of grifolin. Grifolin can mediate its anticancer
    actions through three fundamental mechanisms. (1) Grifolin can induce an increase
    of Bax and a decrease of Bcl2 in Mitochondria which exhibit a release of cytochrome
    C and an eventual increase of caspase 3 cleave PAPR proteins, thus inducing intrinsic
    apoptotic action. (2) Grifolin can inhibit the ERK1/2 pathway and increase the
    expression of DNMT1, which plays a key role in maintaining of cell memory with
    inhibiting cell proliferation. (3) Grifolin can induce senescence of cancerous
    cells through cell cycle arrest (via inhibiting inhibition CDK4, cyclin E, and
    cyclin D1 regulator proteins) and a decrease of RB phosphorylation. Abbreviations:
    DNMT1, DNA Methyltransferase 1; ERK1/2, extracellular signal-regulated kinases
    1 and 2; Bcl, B cell lymphoma; Bax, BCL2-associated X protein; RB, retinoblastoma
    protein; PARP, poly (ADP-ribose) polymerase; CDK, cyclin-dependent kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Bcl2
  - Bax
  - Nkx3-1
  - Parp1
  - Casp3
  - Mapk3
  - Mapk1
  - Dnmt1
  - oh
  - Cdk4
  - Map6
  - BCL2
  - BAX
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - MAPK3
  - MAPK1
  - DNMT1
  - CCNE1
  - CCNE2
  - CDK4
  - MAP6
  - Defb1
  - Ccne1
---
